Genmab AS (GMAB) — Cash Flow-to-Debt Ratio
Genmab AS (GMAB) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of $300.34 Million could theoretically repay 0% of its total liabilities ($7.01 Billion) in one year. See Genmab AS free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genmab AS Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Genmab AS across 24 annual periods. Also explore GMAB net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Genmab AS (2002–2025)
Year-by-year debt coverage analysis for Genmab AS. For market capitalisation and broader financial context, see Genmab AS (GMAB) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | $1.19 Billion | $7.01 Billion | ▼ -80.1% |
| 2024 | 0.85x | $7.77 Billion | $9.11 Billion | ▼ -57.5% |
| 2023 | 2.01x | $7.38 Billion | $3.68 Billion | ▲ +45.5% |
| 2022 | 1.38x | $3.91 Billion | $2.84 Billion | ▲ +50.5% |
| 2021 | 0.92x | $2.23 Billion | $2.43 Billion | ▼ -71.2% |
| 2020 | 3.18x | $6.43 Billion | $2.02 Billion | ▲ +163.0% |
| 2019 | 1.21x | $1.33 Billion | $1.10 Billion | ▼ -46.8% |
| 2018 | 2.27x | $1.01 Billion | $446.64 Million | ▼ -52.7% |
| 2017 | 4.80x | $1.59 Billion | $330.75 Million | ▲ +503.3% |
| 2016 | 0.80x | $327.72 Million | $411.54 Million | ▲ +6.3% |
| 2015 | 0.75x | $311.45 Million | $415.83 Million | ▲ +370.7% |
| 2014 | 0.16x | $132.67 Million | $833.74 Million | ▲ +233.3% |
| 2013 | -0.12x | $-128.00 Million | $1.07 Billion | ▼ -320.5% |
| 2012 | 0.05x | $70.92 Million | $1.31 Billion | ▲ +113.4% |
| 2011 | -0.41x | $-437.23 Million | $1.08 Billion | ▼ -312.0% |
| 2010 | 0.19x | $268.17 Million | $1.40 Billion | ▲ +131.0% |
| 2009 | -0.62x | $-570.06 Million | $924.34 Million | ▼ -28.6% |
| 2008 | -0.48x | $-513.33 Million | $1.07 Billion | ▼ -202.0% |
| 2007 | 0.47x | $505.90 Million | $1.08 Billion | ▲ +124.4% |
| 2006 | -1.93x | $-379.62 Million | $197.05 Million | ▼ -132.4% |
| 2005 | -0.83x | $-208.64 Million | $251.66 Million | ▲ +79.5% |
| 2004 | -4.04x | $-367.70 Million | $90.92 Million | ▼ -25.3% |
| 2003 | -3.23x | $-302.36 Million | $93.67 Million | ▼ -92.6% |
| 2002 | -1.68x | $-308.32 Million | $183.97 Million | — |